{"id":"https://openalex.org/W2149773770","doi":null,"title":"Phase I trial of ZD9331, a nonpolyglutamatable thymidylate synthase inhibitor, given as a 5-day continuous infusion to patients with refractory solid malignancies.","display_name":"Phase I trial of ZD9331, a nonpolyglutamatable thymidylate synthase inhibitor, given as a 5-day continuous infusion to patients with refractory solid malignancies.","publication_year":2003,"publication_date":"2003-06-01","ids":{"openalex":"https://openalex.org/W2149773770","mag":"2149773770","pmid":"https://pubmed.ncbi.nlm.nih.gov/12796367"},"language":"en","primary_location":{"id":"pmid:12796367","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12796367","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112398589","display_name":"Charlotte Rees","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charlotte Rees","raw_affiliation_strings":["Institute of Cancer Research, Sutton, Surrey SM2 5NG, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Research, Sutton, Surrey SM2 5NG, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056466058","display_name":"Philip James Beale","orcid":"https://orcid.org/0000-0003-3628-4597","observed_orcids":["https://orcid.org/0000-0003-3628-4597"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Beale","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062111870","display_name":"Jos\u00e9 Manuel Trigo","orcid":"https://orcid.org/0000-0002-4489-2683","observed_orcids":["https://orcid.org/0000-0002-4489-2683"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jose Manuel Trigo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110208438","display_name":"Fraser Mitchell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fraser Mitchell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025928080","display_name":"Ann L. Jackman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Jackman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022811952","display_name":"Robert P. Smith","orcid":"https://orcid.org/0000-0002-7413-4189","observed_orcids":["https://orcid.org/0000-0002-7413-4189"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108498781","display_name":"Edwin C. Douglass","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edwin Douglass","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5053304892","display_name":"Ian Robert Judson","orcid":"https://orcid.org/0000-0002-4766-5304","observed_orcids":["https://orcid.org/0000-0002-4766-5304"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ian Judson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1644,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.76286301,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"9","issue":"6","first_page":"2049","last_page":"55"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.4948999881744385,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.4948999881744385,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.1761000007390976,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10499","display_name":"Folate and B Vitamins Research","score":0.09149999916553497,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thymidylate-synthase-inhibitors","display_name":"thymidylate synthase inhibitors","score":0.9290000200271606},{"id":"https://openalex.org/keywords/antifolate-drugs","display_name":"antifolate","score":0.9089999794960022},{"id":"https://openalex.org/keywords/continuous-infusion","display_name":"continuous infusion","score":0.5360000133514404},{"id":"https://openalex.org/keywords/refractory-solid-tumors","display_name":"refractory solid tumors","score":0.9430000185966492},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7950000166893005},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9909999966621399},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9660000205039978},{"id":"https://openalex.org/keywords/2-deoxyuridine","display_name":"2'-deoxyuridine","score":0.8920000195503235},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8479999899864197},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.824999988079071}],"concepts":[{"id":"https://openalex.org/C123321153","wikidata":"https://www.wikidata.org/wiki/Q22676802","display_name":"Thymidylate synthase","level":4,"score":0.8503369688987732},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6621185541152954},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6621118783950806},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6453741788864136},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5541547536849976},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5509259104728699},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5429252982139587},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5328925848007202},{"id":"https://openalex.org/C2777260799","wikidata":"https://www.wikidata.org/wiki/Q15637420","display_name":"Lethargy","level":2,"score":0.5317831039428711},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.5155827403068542},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.47830110788345337},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4677432179450989},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.22689801454544067},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1336086094379425},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12796367","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12796367","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},{"id":"mag:2149773770","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12796367","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W1873275656","https://openalex.org/W1898359977","https://openalex.org/W1965991863","https://openalex.org/W1977715167","https://openalex.org/W1978168871","https://openalex.org/W2048172518","https://openalex.org/W2051403632","https://openalex.org/W2058046427","https://openalex.org/W2060897854","https://openalex.org/W2110519215","https://openalex.org/W2128641103","https://openalex.org/W2147271502","https://openalex.org/W2153567179"],"related_works":["https://openalex.org/W2107021125","https://openalex.org/W2326809111","https://openalex.org/W1972746240","https://openalex.org/W1898359977","https://openalex.org/W7095674245","https://openalex.org/W2128641103","https://openalex.org/W2045794213","https://openalex.org/W1964291834","https://openalex.org/W2318216035","https://openalex.org/W2056926730"],"abstract_inverted_index":{"PURPOSE:":[0],"This":[1],"dose-escalating":[2],"study":[3],"investigated":[4],"the":[5,11,80,135],"toxicity,":[6,66],"pharmacokinetics,":[7],"and":[8,64,68,77,88,118,134,144,159],"efficacy":[9],"of":[10,49,103,147,152,161],"novel":[12],"direct-acting":[13],"antifolate":[14],"ZD9331,":[15,34],"given":[16],"as":[17,131],"a":[18,109],"5-day":[19],"i.v.":[20],"infusion":[21],"every":[22],"3":[23,48],"weeks.":[24],"EXPERIMENTAL":[25],"DESIGN:":[26],"Forty-five":[27],"patients":[28,51,107,120],"with":[29,83],"refractory":[30],"solid":[31],"malignancies":[32],"received":[33],"which":[35],"was":[36,86,129,141,164],"escalated":[37],"from":[38],"0.125":[39],"mg/m(2)/day.":[40],"RESULTS:":[41],"Dose-limiting":[42],"grade":[43],"4":[44],"thrombocytopenia":[45],"occurred":[46],"in":[47],"6":[50,132],"treated":[52],"at":[53],"8":[54],"mg/m(2)/day;":[55],"other":[56],"drug-related":[57],"toxicities,":[58],"across":[59],"dose":[60,128],"levels,":[61,154],"included":[62],"skin":[63],"gastrointestinal":[65],"lethargy,":[67],"asymptomatic,":[69],"reversible,":[70],"elevated":[71,99],"transaminases.":[72],"The":[73,125],"maximum":[74,126],"plasma":[75,95],"concentration":[76],"area":[78],"under":[79],"curve":[81],"increased":[82],"dose.":[84],"Clearance":[85],"dose-dependent":[87],"predominantly":[89],"renal.":[90],"At":[91],"doses":[92],">/=2.4":[93],"mg/m(2)/day,":[94,133],"2'-deoxyuridine":[96,153],"levels":[97],"were":[98],"consistently":[100],"indicating":[101],"inhibition":[102],"thymidylate":[104,156],"synthase.":[105],"Two":[106],"had":[108,121],"partial":[110],"response":[111],"(breast,":[112],"1":[113,116],"patient;":[114],"ovarian,":[115],"patient),":[117],"10":[119],"stable":[122],"disease.":[123],"CONCLUSION:":[124],"tolerated":[127],"defined":[130],"toxicity":[136],"profile":[137],"for":[138],"this":[139],"regimen":[140],"considered":[142],"acceptable":[143],"manageable.":[145],"Administration":[146],"ZD9331":[148],"lead":[149],"to":[150],"elevation":[151],"signifying":[155],"synthase":[157],"inhibition,":[158],"evidence":[160],"antitumor":[162],"activity":[163],"observed.":[165]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}